Koji Izutsu, Takahiro Kumode, Junichiro Yuda, Hirokazu Nagai, Yuko Mishima, Youko Suehiro, Kazuhito Yamamoto, Tomoaki Fujisaki, Kenji Ishitsuka, Kenichi Ishizawa, et al. Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphoma. Cancer science. 2023. 114. 12. 4643-4653
Takahiro Haeno, Shinya Rai, Yoshiaki Miyake, Maiko Inoue, Ko Fujimoto, Aki Fujii, Yoshio Iwata, Shuji Minamoto, Takahide Taniguchi, Hiroaki Kakutani, et al. Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma. Journal of clinical and experimental hematopathology : JCEH. 2023. 63. 2. 99-107
Ryosuke Fujiwara, Yasuhiro Taniguchi, Shinya Rai, Yoshio Iwata, Aki Fujii, Ko Fujimoto, Takahiro Kumode, Kentaro Serizawa, Yasuyoshi Morita, J Luis Espinoza, et al. Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells. Biochemical and biophysical research communications. 2022. 626. 156-166
Takahiro Kumode, Hirokazu Tanaka, Jorge Luis Esipinoza, Shinya Rai, Yasuhiro Taniguchi, Ryosuke Fujiwara, Keigo Sano, Kentaro Serizawa, Yoshio Iwata, Yasuyoshi Morita, et al. C-type lectin-like receptor 2 specifies a functionally distinct subpopulation within phenotypically defined hematopoietic stem cell population that contribute to emergent megakaryopoiesis. International journal of hematology. 2022. 115. 3. 310-321
Kentaro Serizawa, Hirokazu Tanaka, Takeshi Ueda, Ayano Fukui, Hiroaki Kakutani, Takahide Taniguchi, Hiroaki Inoue, Takahiro Kumode, Yasuhiro Taniguchi, Shinya Rai, et al. CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence. International Journal of Hematology. 2022. 115. 3. 336-349
波江野高大, 三宅義昭, 井上舞子, 藤本昂, 角谷宏明, 藤井晶, 源周治, 口分田貴裕, 芹澤憲太郎, 谷口康博, et al. Retrospective analysis of autologous stem cell transplantation for Diffuse large B-cell lymphoma. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
鳥畑さやか, 下出孟史, 助臺美帆, 岩崎早苗, 李篤史, 金澤仁美, 兵頭咲紀, 松浦可歩, 三宅義昭, 波江野高大, et al. Association between D-index and severity of oral mucositis in patients undergoing allo-HSCT pretreat. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th
井上宏昭, 頼晋也, 口分田貴裕, 芹澤憲太郎, 谷口康博, 中山聖子, 森田泰慶, LUIS Espinoza J, 田中宏和, 辰巳陽一, et al. 十二指腸原発濾胞性リンパ腫における抗腫瘍免疫の寄与. 日本リンパ網内系学会会誌. 2019. 59
SUMO化阻害薬とrituximabのマクロファージおよびNK細胞活性-The activity of macrophage and NK cell induced by the combined treatment with SUMOylation inhibitor and rituximab
科学評論社 2023
Lectures and oral presentations (50):
フルダラビン+ブスルファンを用いた同種造血幹細胞移植における重症口腔粘膜炎発症のリスク因子の解析(Risk factor of oral mucositis after allogeneic hematopoietic stem cell transplantation using FLU/BU)
(日本血液学会学術集会 2021)
Gilteritinib treatment for extramedullary relapse of FLT3-ITD acute myeloid leukemia
(日本造血細胞移植学会総会プログラム・抄録集 2021)
Clinical usefulness of Letermovir for patients with stem cell transplantation
(日本造血細胞移植学会総会プログラム・抄録集 2021)
CMML様の病型移行を来したMDSに対してアザシチジンが有効であった1例
(臨床血液 2021)
Outcomes of allo-SCT for patients in non-remission especially with chemoresistance
(日本造血細胞移植学会総会プログラム・抄録集 2020)
THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY
, 日本臨床腫瘍学会
, 日本リンパ網内系学会
, 日本造血細胞移植学会
, THE JAPANESE SOCIETY OF HEMATOLOGY
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE